Previous Close | 20.84 |
1-Year Change | -9.31% |
6-Months Change | -25.2% |
3-Months Change | -0.05% |
Moving Avg (50d) | 20.722 |
Moving Avg (200d) | 24.448 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.88B |
Beta (3-Years) | 1.87 |
Revenue Growth (ttm) | % |
Net Profit Margin (ttm) | % |
Return On Assets (ttm) | -42.2% |
EPS (ttm) | -3.19 |
PE Ratio (ttm) | -6.53 |
Dividend Yield | % |
Asset Description: | Rocket Pharmaceuticals, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-09-17 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
20.423 | 19.798 | 19.381 | 18.756 | 17.714 | 16.672 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.